Prudential plc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Prudential plc’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,460	Closed	-$356K	–	766
2025 Q1	$356K	Hold	1,460	–	–	﹤0.01%	652
2024 Q4	$480K	Hold	1,460	–	–	﹤0.01%	626
2024 Q3	$488K	Hold	1,460	–	–	﹤0.01%	646
2024 Q2	$399K	Buy	+1,460	New	+$425K	﹤0.01%	646
2024 Q1	–	Sell	-1,592	Closed	-$514K	–	760
2023 Q4	$514K	Buy	1,592 +2	+0.1%	+$627	0.01%	772
2023 Q3	$570K	Sell	1,590 -12	-0.7%	-$4.63K	0.01%	711
2023 Q2	$607K	Sell	1,602 -9	-0.6%	-$3.66K	0.01%	724
2023 Q1	$772K	Sell	1,611 -311	-16%	-$146K	0.01%	639
2022 Q4	$808K	Buy	1,922 +1,138	+145%	+$459K	0.01%	618
2022 Q3	$327K	Buy	784 +80	+11%	+$39.9K	0.01%	686
2022 Q2	$348K	Buy	704 +68	+11%	+$35.4K	0.01%	653
2022 Q1	$358K	Buy	+636	New	+$383K	0.01%	681

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Prudential plc's BIO Position: Q2 2025 in Review

Prudential plc sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 1,460 shares — an estimated $356K sold.

Prudential plc first reported a position in BIO in Q1 2022 and held it in 12 quarters. The position peaked at $808K in Q4 2022. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

Prudential plc reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
Prudential plc sold 1,460 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $356K.
Prudential plc first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and held it in 12 quarters.
Prudential plc's Bio-Rad Laboratories Class A position peaked at $808K in Q4 2022.
384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Prudential plc's 13F filing for Q2 2025, filed 12 Aug 2025.